Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELTROMBOPAG OLAMINE Cause Visual impairment? 142 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Visual impairment have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 0.9% of all adverse event reports for ELTROMBOPAG OLAMINE.

142
Reports of Visual impairment with ELTROMBOPAG OLAMINE
0.9%
of all ELTROMBOPAG OLAMINE reports
5
Deaths
34
Hospitalizations

How Dangerous Is Visual impairment From ELTROMBOPAG OLAMINE?

Of the 142 reports, 5 (3.5%) resulted in death, 34 (23.9%) required hospitalization, and 17 (12.0%) were considered life-threatening.

Is Visual impairment Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 142 reports have been filed with the FAERS database.

What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?

Platelet count decreased (3,419) Death (2,797) Drug ineffective (1,117) Platelet count increased (980) Fatigue (868) Headache (750) Nausea (584) Diarrhoea (558) Product use in unapproved indication (545) Malaise (516)

What Other Drugs Cause Visual impairment?

INSULIN GLARGINE (5,793) INSULIN LISPRO (4,654) ADALIMUMAB (3,770) DUPILUMAB (3,089) ETANERCEPT (2,489) FINGOLIMOD (2,147) AFLIBERCEPT (1,836) PREGABALIN (1,714) METHOTREXATE (1,588) TOFACITINIB (1,544)

Which ELTROMBOPAG OLAMINE Alternatives Have Lower Visual impairment Risk?

ELTROMBOPAG OLAMINE vs ELUXADOLINE ELTROMBOPAG OLAMINE vs ELVITEGRAVIR ELTROMBOPAG OLAMINE vs EMAPALUMAB ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG ELTROMBOPAG OLAMINE vs EMEND

Related Pages

ELTROMBOPAG OLAMINE Full Profile All Visual impairment Reports All Drugs Causing Visual impairment ELTROMBOPAG OLAMINE Demographics